# Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction

> **NCT01876810** · PHASE2 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 28 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Gemfibrozil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01876810
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01876810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01876810, "Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01876810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*